REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nuvital S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Other Direct Selling Establishments
Full name: Nuvital S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Nuvital S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on October 22, 2020. The total number of employees is currently 4 (2023). From the latest financial highlights, Nuvital S.A. reported a net sales revenue increase of 119.84% in 2023. Its’ total assets recorded a negative growth of 43.67%. Nuvital S.A.’s net profit margin increased by 1375.47% in 2023.

Headquarters
Av. Isidro Ayora Km. 12.5
Guayaquil; Guayas;

Contact Details: Purchase the Nuvital S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Nuvital S.A. report to view the information.
Outstanding Shares:
Purchase the Nuvital S.A. report to view the information.
Registered Capital:
Purchase the Nuvital S.A. report to view the information.
Incorporation Date:
October 22, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Nuvital S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
119.84%▲
Total operating revenue
119.84%▲
Operating profit (EBIT)
99.74%▲
Net Profit (Loss) for the Period
99.71%▲
Total assets
-43.67%▼
Total equity
-0.19%▼
Operating Profit Margin (ROS)
1350.18%▲
Net Profit Margin
1375.47%▲
Return on Equity (ROE)
-65.08%▼
Quick Ratio
-1.44%▼
Cash Ratio
-0.56%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo